nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—HTR1B—obesity	0.184	0.607	CbGaD
Ondansetron—SLC47A1—Cimetidine—obesity	0.123	0.286	CbGbCtD
Ondansetron—CYP2E1—obesity	0.119	0.393	CbGaD
Ondansetron—CYP2E1—Bupropion—obesity	0.0273	0.0634	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Cimetidine—obesity	0.0208	0.0482	CbGbCtD
Ondansetron—CYP3A7—Cimetidine—obesity	0.0208	0.0482	CbGbCtD
Ondansetron—CYP2E1—Cimetidine—obesity	0.02	0.0466	CbGbCtD
Ondansetron—CYP1A2—Phentermine—obesity	0.0186	0.0432	CbGbCtD
Ondansetron—CYP1A2—Phenylpropanolamine—obesity	0.0177	0.0412	CbGbCtD
Ondansetron—CYP2C9—Phentermine—obesity	0.0167	0.0389	CbGbCtD
Ondansetron—CYP1A2—Bupropion—obesity	0.0158	0.0367	CbGbCtD
Ondansetron—CYP3A5—Cimetidine—obesity	0.0156	0.0362	CbGbCtD
Ondansetron—CYP2D6—Phentermine—obesity	0.0153	0.0356	CbGbCtD
Ondansetron—CYP2C9—Bupropion—obesity	0.0142	0.0331	CbGbCtD
Ondansetron—HTR3A—area postrema—obesity	0.0131	0.294	CbGeAlD
Ondansetron—CYP2D6—Bupropion—obesity	0.013	0.0302	CbGbCtD
Ondansetron—CYP3A4—Sibutramine—obesity	0.0128	0.0298	CbGbCtD
Ondansetron—CYP2D6—Methamphetamine—obesity	0.0122	0.0284	CbGbCtD
Ondansetron—CYP1A2—Cimetidine—obesity	0.0116	0.0269	CbGbCtD
Ondansetron—CYP2C9—Cimetidine—obesity	0.0104	0.0243	CbGbCtD
Ondansetron—CYP3A4—Benzphetamine—obesity	0.00973	0.0226	CbGbCtD
Ondansetron—CYP2D6—Cimetidine—obesity	0.00955	0.0222	CbGbCtD
Ondansetron—CYP3A4—Bupropion—obesity	0.00827	0.0192	CbGbCtD
Ondansetron—CYP3A4—Orlistat—obesity	0.00674	0.0157	CbGbCtD
Ondansetron—CYP3A4—Cimetidine—obesity	0.00607	0.0141	CbGbCtD
Ondansetron—HTR3A—vagus nerve—obesity	0.00438	0.0979	CbGeAlD
Ondansetron—CYP3A4—Topiramate—obesity	0.00397	0.00924	CbGbCtD
Ondansetron—HTR4—adrenal cortex—obesity	0.00243	0.0543	CbGeAlD
Ondansetron—HTR4—pituitary gland—obesity	0.00196	0.0439	CbGeAlD
Ondansetron—Alosetron—CYP2E1—obesity	0.00178	1	CrCbGaD
Ondansetron—HTR4—adrenal gland—obesity	0.00175	0.0392	CbGeAlD
Ondansetron—SLC47A2—digestive system—obesity	0.0014	0.0312	CbGeAlD
Ondansetron—SLC47A1—hindbrain—obesity	0.00126	0.0281	CbGeAlD
Ondansetron—HTR1A—hindbrain—obesity	0.000867	0.0194	CbGeAlD
Ondansetron—HTR3A—islet of Langerhans—obesity	0.000828	0.0185	CbGeAlD
Ondansetron—HTR3A—respiratory system—obesity	0.000782	0.0175	CbGeAlD
Ondansetron—SLC47A1—adrenal cortex—obesity	0.000645	0.0144	CbGeAlD
Ondansetron—CYP3A7—endocrine gland—obesity	0.000581	0.013	CbGeAlD
Ondansetron—CYP3A7—liver—obesity	0.000524	0.0117	CbGeAlD
Ondansetron—SLC47A1—pituitary gland—obesity	0.000521	0.0116	CbGeAlD
Ondansetron—SLC47A1—adipose tissue—obesity	0.000519	0.0116	CbGeAlD
Ondansetron—HTR1B—cardiovascular system—obesity	0.000502	0.0112	CbGeAlD
Ondansetron—KCNH2—islet of Langerhans—obesity	0.000499	0.0112	CbGeAlD
Ondansetron—HTR3A—digestive system—obesity	0.000497	0.0111	CbGeAlD
Ondansetron—SLC47A1—digestive system—obesity	0.000488	0.0109	CbGeAlD
Ondansetron—CYP2D6—hindbrain—obesity	0.000471	0.0105	CbGeAlD
Ondansetron—SLC47A1—adrenal gland—obesity	0.000465	0.0104	CbGeAlD
Ondansetron—CYP3A7-CYP3A51P—liver—obesity	0.000445	0.00995	CbGeAlD
Ondansetron—CYP3A5—islet of Langerhans—obesity	0.000412	0.00921	CbGeAlD
Ondansetron—HTR1A—cardiovascular system—obesity	0.000405	0.00906	CbGeAlD
Ondansetron—SLC47A1—endocrine gland—obesity	0.000403	0.00902	CbGeAlD
Ondansetron—CYP1A2—respiratory system—obesity	0.000403	0.00902	CbGeAlD
Ondansetron—CYP3A5—respiratory system—obesity	0.000389	0.0087	CbGeAlD
Ondansetron—OPRM1—endocrine gland—obesity	0.000377	0.00842	CbGeAlD
Ondansetron—SLC47A1—liver—obesity	0.000364	0.00813	CbGeAlD
Ondansetron—CYP2E1—respiratory system—obesity	0.000363	0.00811	CbGeAlD
Ondansetron—KCNH2—cardiovascular system—obesity	0.000361	0.00807	CbGeAlD
Ondansetron—HTR1B—endocrine gland—obesity	0.000345	0.0077	CbGeAlD
Ondansetron—HTR1A—adrenal gland—obesity	0.000321	0.00717	CbGeAlD
Ondansetron—KCNH2—pituitary gland—obesity	0.00032	0.00714	CbGeAlD
Ondansetron—CYP2C9—cardiovascular system—obesity	0.000293	0.00656	CbGeAlD
Ondansetron—KCNH2—adrenal gland—obesity	0.000285	0.00638	CbGeAlD
Ondansetron—HTR1A—endocrine gland—obesity	0.000278	0.00622	CbGeAlD
Ondansetron—CYP2E1—cardiovascular system—obesity	0.000278	0.00621	CbGeAlD
Ondansetron—Urticaria—Diethylpropion—obesity	0.000263	0.00227	CcSEcCtD
Ondansetron—Dizziness—Phenylpropanolamine—obesity	0.000263	0.00227	CcSEcCtD
Ondansetron—CYP3A5—adipose tissue—obesity	0.000263	0.00587	CbGeAlD
Ondansetron—Diarrhoea—Phentermine—obesity	0.000261	0.00225	CcSEcCtD
Ondansetron—Acute coronary syndrome—Sibutramine—obesity	0.00026	0.00224	CcSEcCtD
Ondansetron—Feeling abnormal—Cimetidine—obesity	0.00026	0.00224	CcSEcCtD
Ondansetron—Myocardial infarction—Sibutramine—obesity	0.000259	0.00223	CcSEcCtD
Ondansetron—Asthma—Bupropion—obesity	0.000258	0.00222	CcSEcCtD
Ondansetron—Hepatobiliary disease—Orlistat—obesity	0.000258	0.00222	CcSEcCtD
Ondansetron—Urinary tract infection—Sibutramine—obesity	0.000257	0.00221	CcSEcCtD
Ondansetron—CYP1A2—digestive system—obesity	0.000256	0.00573	CbGeAlD
Ondansetron—Bronchospasm—Bupropion—obesity	0.000254	0.00219	CcSEcCtD
Ondansetron—Vomiting—Phenylpropanolamine—obesity	0.000253	0.00218	CcSEcCtD
Ondansetron—Dizziness—Phentermine—obesity	0.000252	0.00217	CcSEcCtD
Ondansetron—Rash—Phenylpropanolamine—obesity	0.000251	0.00216	CcSEcCtD
Ondansetron—Dermatitis—Phenylpropanolamine—obesity	0.000251	0.00216	CcSEcCtD
Ondansetron—Body temperature increased—Cimetidine—obesity	0.000249	0.00215	CcSEcCtD
Ondansetron—KCNH2—endocrine gland—obesity	0.000248	0.00553	CbGeAlD
Ondansetron—CYP3A5—digestive system—obesity	0.000247	0.00553	CbGeAlD
Ondansetron—Haemoglobin—Orlistat—obesity	0.000246	0.00212	CcSEcCtD
Ondansetron—Haemorrhage—Orlistat—obesity	0.000245	0.00211	CcSEcCtD
Ondansetron—CYP2C9—digestive system—obesity	0.000243	0.00544	CbGeAlD
Ondansetron—Vomiting—Phentermine—obesity	0.000242	0.00209	CcSEcCtD
Ondansetron—Dysuria—Bupropion—obesity	0.000241	0.00208	CcSEcCtD
Ondansetron—Bradycardia—Sibutramine—obesity	0.000241	0.00208	CcSEcCtD
Ondansetron—Rash—Phentermine—obesity	0.00024	0.00207	CcSEcCtD
Ondansetron—Dermatitis—Phentermine—obesity	0.00024	0.00207	CcSEcCtD
Ondansetron—Headache—Phentermine—obesity	0.000239	0.00206	CcSEcCtD
Ondansetron—Haemoglobin—Sibutramine—obesity	0.000238	0.00205	CcSEcCtD
Ondansetron—Haemorrhage—Sibutramine—obesity	0.000237	0.00204	CcSEcCtD
Ondansetron—Hypersensitivity—Cimetidine—obesity	0.000232	0.002	CcSEcCtD
Ondansetron—CYP2E1—digestive system—obesity	0.000231	0.00516	CbGeAlD
Ondansetron—Visual impairment—Sibutramine—obesity	0.000228	0.00197	CcSEcCtD
Ondansetron—Stevens-Johnson syndrome—Bupropion—obesity	0.000228	0.00197	CcSEcCtD
Ondansetron—Acute coronary syndrome—Bupropion—obesity	0.000227	0.00196	CcSEcCtD
Ondansetron—Diarrhoea—Diethylpropion—obesity	0.000227	0.00195	CcSEcCtD
Ondansetron—Asthenia—Cimetidine—obesity	0.000226	0.00195	CcSEcCtD
Ondansetron—Myocardial infarction—Bupropion—obesity	0.000226	0.00194	CcSEcCtD
Ondansetron—Urinary tract infection—Bupropion—obesity	0.000224	0.00193	CcSEcCtD
Ondansetron—Eye disorder—Sibutramine—obesity	0.000222	0.00191	CcSEcCtD
Ondansetron—Immune system disorder—Orlistat—obesity	0.000221	0.00191	CcSEcCtD
Ondansetron—Mediastinal disorder—Orlistat—obesity	0.000221	0.0019	CcSEcCtD
Ondansetron—Sleep disorder—Topiramate—obesity	0.00022	0.00189	CcSEcCtD
Ondansetron—CYP2E1—adrenal gland—obesity	0.00022	0.00491	CbGeAlD
Ondansetron—Dizziness—Diethylpropion—obesity	0.000219	0.00189	CcSEcCtD
Ondansetron—Diarrhoea—Cimetidine—obesity	0.000216	0.00186	CcSEcCtD
Ondansetron—Angiopathy—Sibutramine—obesity	0.000215	0.00185	CcSEcCtD
Ondansetron—Immune system disorder—Sibutramine—obesity	0.000214	0.00185	CcSEcCtD
Ondansetron—Chills—Sibutramine—obesity	0.000213	0.00183	CcSEcCtD
Ondansetron—CYP1A2—endocrine gland—obesity	0.000212	0.00474	CbGeAlD
Ondansetron—Hepatic failure—Topiramate—obesity	0.000212	0.00182	CcSEcCtD
Ondansetron—Arrhythmia—Sibutramine—obesity	0.000212	0.00182	CcSEcCtD
Ondansetron—Vomiting—Diethylpropion—obesity	0.000211	0.00181	CcSEcCtD
Ondansetron—Flatulence—Orlistat—obesity	0.00021	0.00181	CcSEcCtD
Ondansetron—Rash—Diethylpropion—obesity	0.000209	0.0018	CcSEcCtD
Ondansetron—Dermatitis—Diethylpropion—obesity	0.000209	0.0018	CcSEcCtD
Ondansetron—Dizziness—Cimetidine—obesity	0.000208	0.0018	CcSEcCtD
Ondansetron—Haemoglobin—Bupropion—obesity	0.000208	0.00179	CcSEcCtD
Ondansetron—Headache—Diethylpropion—obesity	0.000208	0.00179	CcSEcCtD
Ondansetron—Haemorrhage—Bupropion—obesity	0.000207	0.00178	CcSEcCtD
Ondansetron—CYP3A5—endocrine gland—obesity	0.000204	0.00457	CbGeAlD
Ondansetron—Flatulence—Sibutramine—obesity	0.000203	0.00175	CcSEcCtD
Ondansetron—CYP2C9—endocrine gland—obesity	0.000201	0.0045	CbGeAlD
Ondansetron—Vision blurred—Orlistat—obesity	0.000201	0.00173	CcSEcCtD
Ondansetron—Visual disturbance—Topiramate—obesity	0.000201	0.00173	CcSEcCtD
Ondansetron—Vomiting—Cimetidine—obesity	0.0002	0.00173	CcSEcCtD
Ondansetron—Visual impairment—Bupropion—obesity	0.000199	0.00172	CcSEcCtD
Ondansetron—Rash—Cimetidine—obesity	0.000199	0.00171	CcSEcCtD
Ondansetron—Dermatitis—Cimetidine—obesity	0.000199	0.00171	CcSEcCtD
Ondansetron—Ill-defined disorder—Orlistat—obesity	0.000198	0.0017	CcSEcCtD
Ondansetron—Headache—Cimetidine—obesity	0.000197	0.0017	CcSEcCtD
Ondansetron—Erythema multiforme—Bupropion—obesity	0.000195	0.00168	CcSEcCtD
Ondansetron—Angioedema—Orlistat—obesity	0.000195	0.00168	CcSEcCtD
Ondansetron—Vision blurred—Sibutramine—obesity	0.000194	0.00168	CcSEcCtD
Ondansetron—Tremor—Sibutramine—obesity	0.000193	0.00167	CcSEcCtD
Ondansetron—Eye disorder—Bupropion—obesity	0.000193	0.00166	CcSEcCtD
Ondansetron—Malaise—Orlistat—obesity	0.000192	0.00166	CcSEcCtD
Ondansetron—Cardiac disorder—Bupropion—obesity	0.000192	0.00165	CcSEcCtD
Ondansetron—Flushing—Bupropion—obesity	0.000192	0.00165	CcSEcCtD
Ondansetron—Ill-defined disorder—Sibutramine—obesity	0.000191	0.00165	CcSEcCtD
Ondansetron—CYP1A2—liver—obesity	0.000191	0.00427	CbGeAlD
Ondansetron—CYP2E1—endocrine gland—obesity	0.000191	0.00426	CbGeAlD
Ondansetron—Agitation—Sibutramine—obesity	0.00019	0.00163	CcSEcCtD
Ondansetron—Angioedema—Sibutramine—obesity	0.000189	0.00162	CcSEcCtD
Ondansetron—Palpitations—Orlistat—obesity	0.000188	0.00162	CcSEcCtD
Ondansetron—Angiopathy—Bupropion—obesity	0.000187	0.00162	CcSEcCtD
Ondansetron—Immune system disorder—Bupropion—obesity	0.000187	0.00161	CcSEcCtD
Ondansetron—Mediastinal disorder—Bupropion—obesity	0.000186	0.0016	CcSEcCtD
Ondansetron—Malaise—Sibutramine—obesity	0.000186	0.0016	CcSEcCtD
Ondansetron—Cough—Orlistat—obesity	0.000186	0.0016	CcSEcCtD
Ondansetron—CYP3A4—digestive system—obesity	0.000186	0.00415	CbGeAlD
Ondansetron—Chills—Bupropion—obesity	0.000185	0.0016	CcSEcCtD
Ondansetron—Syncope—Sibutramine—obesity	0.000185	0.00159	CcSEcCtD
Ondansetron—Convulsion—Orlistat—obesity	0.000185	0.00159	CcSEcCtD
Ondansetron—Arrhythmia—Bupropion—obesity	0.000185	0.00159	CcSEcCtD
Ondansetron—CYP3A5—liver—obesity	0.000184	0.00412	CbGeAlD
Ondansetron—CYP2D6—digestive system—obesity	0.000183	0.00408	CbGeAlD
Ondansetron—Palpitations—Sibutramine—obesity	0.000182	0.00157	CcSEcCtD
Ondansetron—Chest pain—Orlistat—obesity	0.000182	0.00156	CcSEcCtD
Ondansetron—CYP2C9—liver—obesity	0.000181	0.00405	CbGeAlD
Ondansetron—Loss of consciousness—Sibutramine—obesity	0.000181	0.00156	CcSEcCtD
Ondansetron—Urinary retention—Topiramate—obesity	0.000181	0.00156	CcSEcCtD
Ondansetron—Anxiety—Orlistat—obesity	0.000181	0.00156	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00018	0.00155	CcSEcCtD
Ondansetron—Cough—Sibutramine—obesity	0.00018	0.00155	CcSEcCtD
Ondansetron—Discomfort—Orlistat—obesity	0.000179	0.00155	CcSEcCtD
Ondansetron—Convulsion—Sibutramine—obesity	0.000179	0.00154	CcSEcCtD
Ondansetron—Dry mouth—Orlistat—obesity	0.000178	0.00153	CcSEcCtD
Ondansetron—Flatulence—Bupropion—obesity	0.000177	0.00153	CcSEcCtD
Ondansetron—Liver function test abnormal—Topiramate—obesity	0.000176	0.00151	CcSEcCtD
Ondansetron—Chest pain—Sibutramine—obesity	0.000176	0.00151	CcSEcCtD
Ondansetron—Anxiety—Sibutramine—obesity	0.000175	0.00151	CcSEcCtD
Ondansetron—Anaphylactic shock—Orlistat—obesity	0.000174	0.0015	CcSEcCtD
Ondansetron—Discomfort—Sibutramine—obesity	0.000174	0.0015	CcSEcCtD
Ondansetron—Hypokalaemia—Topiramate—obesity	0.000173	0.00149	CcSEcCtD
Ondansetron—CYP2E1—liver—obesity	0.000172	0.00384	CbGeAlD
Ondansetron—Dry mouth—Sibutramine—obesity	0.000172	0.00148	CcSEcCtD
Ondansetron—Toxic epidermal necrolysis—Topiramate—obesity	0.000171	0.00148	CcSEcCtD
Ondansetron—Aspartate aminotransferase increased—Topiramate—obesity	0.000171	0.00148	CcSEcCtD
Ondansetron—Nervous system disorder—Orlistat—obesity	0.000171	0.00147	CcSEcCtD
Ondansetron—Vision blurred—Bupropion—obesity	0.00017	0.00146	CcSEcCtD
Ondansetron—Skin disorder—Orlistat—obesity	0.000169	0.00146	CcSEcCtD
Ondansetron—Tremor—Bupropion—obesity	0.000169	0.00145	CcSEcCtD
Ondansetron—Anaphylactic shock—Sibutramine—obesity	0.000168	0.00145	CcSEcCtD
Ondansetron—Ill-defined disorder—Bupropion—obesity	0.000167	0.00144	CcSEcCtD
Ondansetron—Shock—Sibutramine—obesity	0.000166	0.00143	CcSEcCtD
Ondansetron—Agitation—Bupropion—obesity	0.000165	0.00142	CcSEcCtD
Ondansetron—Asthma—Topiramate—obesity	0.000164	0.00142	CcSEcCtD
Ondansetron—Angioedema—Bupropion—obesity	0.000164	0.00142	CcSEcCtD
Ondansetron—Tachycardia—Sibutramine—obesity	0.000164	0.00142	CcSEcCtD
Ondansetron—Skin disorder—Sibutramine—obesity	0.000164	0.00141	CcSEcCtD
Ondansetron—Malaise—Bupropion—obesity	0.000162	0.0014	CcSEcCtD
Ondansetron—Syncope—Bupropion—obesity	0.000161	0.00139	CcSEcCtD
Ondansetron—Angina pectoris—Topiramate—obesity	0.00016	0.00138	CcSEcCtD
Ondansetron—Palpitations—Bupropion—obesity	0.000159	0.00137	CcSEcCtD
Ondansetron—Loss of consciousness—Bupropion—obesity	0.000158	0.00136	CcSEcCtD
Ondansetron—Hypotension—Sibutramine—obesity	0.000157	0.00136	CcSEcCtD
Ondansetron—Cough—Bupropion—obesity	0.000157	0.00135	CcSEcCtD
Ondansetron—Paraesthesia—Orlistat—obesity	0.000156	0.00135	CcSEcCtD
Ondansetron—Convulsion—Bupropion—obesity	0.000156	0.00134	CcSEcCtD
Ondansetron—Dysuria—Topiramate—obesity	0.000154	0.00133	CcSEcCtD
Ondansetron—CYP3A4—endocrine gland—obesity	0.000153	0.00343	CbGeAlD
Ondansetron—Chest pain—Bupropion—obesity	0.000153	0.00132	CcSEcCtD
Ondansetron—Anxiety—Bupropion—obesity	0.000153	0.00132	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000152	0.00131	CcSEcCtD
Ondansetron—Discomfort—Bupropion—obesity	0.000151	0.0013	CcSEcCtD
Ondansetron—Paraesthesia—Sibutramine—obesity	0.000151	0.0013	CcSEcCtD
Ondansetron—CYP2D6—endocrine gland—obesity	0.000151	0.00337	CbGeAlD
Ondansetron—Gastrointestinal disorder—Orlistat—obesity	0.00015	0.00129	CcSEcCtD
Ondansetron—Dyspnoea—Sibutramine—obesity	0.00015	0.00129	CcSEcCtD
Ondansetron—Fatigue—Orlistat—obesity	0.00015	0.00129	CcSEcCtD
Ondansetron—Dry mouth—Bupropion—obesity	0.00015	0.00129	CcSEcCtD
Ondansetron—Somnolence—Sibutramine—obesity	0.00015	0.00129	CcSEcCtD
Ondansetron—Pain—Orlistat—obesity	0.000149	0.00128	CcSEcCtD
Ondansetron—Anaphylactic shock—Bupropion—obesity	0.000147	0.00127	CcSEcCtD
Ondansetron—Stevens-Johnson syndrome—Topiramate—obesity	0.000145	0.00125	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Sibutramine—obesity	0.000145	0.00125	CcSEcCtD
Ondansetron—Shock—Bupropion—obesity	0.000144	0.00124	CcSEcCtD
Ondansetron—Pain—Sibutramine—obesity	0.000144	0.00124	CcSEcCtD
Ondansetron—Constipation—Sibutramine—obesity	0.000144	0.00124	CcSEcCtD
Ondansetron—Nervous system disorder—Bupropion—obesity	0.000144	0.00124	CcSEcCtD
Ondansetron—Feeling abnormal—Orlistat—obesity	0.000143	0.00124	CcSEcCtD
Ondansetron—Tachycardia—Bupropion—obesity	0.000143	0.00123	CcSEcCtD
Ondansetron—Skin disorder—Bupropion—obesity	0.000143	0.00123	CcSEcCtD
Ondansetron—Urinary tract infection—Topiramate—obesity	0.000143	0.00123	CcSEcCtD
Ondansetron—Gastrointestinal pain—Orlistat—obesity	0.000142	0.00123	CcSEcCtD
Ondansetron—Feeling abnormal—Sibutramine—obesity	0.000139	0.0012	CcSEcCtD
Ondansetron—CYP3A4—liver—obesity	0.000138	0.00309	CbGeAlD
Ondansetron—Urticaria—Orlistat—obesity	0.000138	0.00119	CcSEcCtD
Ondansetron—Gastrointestinal pain—Sibutramine—obesity	0.000138	0.00119	CcSEcCtD
Ondansetron—Abdominal pain—Orlistat—obesity	0.000138	0.00119	CcSEcCtD
Ondansetron—Body temperature increased—Orlistat—obesity	0.000138	0.00119	CcSEcCtD
Ondansetron—Hypotension—Bupropion—obesity	0.000137	0.00118	CcSEcCtD
Ondansetron—CYP2D6—liver—obesity	0.000136	0.00304	CbGeAlD
Ondansetron—Bradycardia—Topiramate—obesity	0.000134	0.00115	CcSEcCtD
Ondansetron—Urticaria—Sibutramine—obesity	0.000134	0.00115	CcSEcCtD
Ondansetron—Body temperature increased—Sibutramine—obesity	0.000133	0.00115	CcSEcCtD
Ondansetron—Abdominal pain—Sibutramine—obesity	0.000133	0.00115	CcSEcCtD
Ondansetron—Haemoglobin—Topiramate—obesity	0.000132	0.00114	CcSEcCtD
Ondansetron—Paraesthesia—Bupropion—obesity	0.000132	0.00114	CcSEcCtD
Ondansetron—Haemorrhage—Topiramate—obesity	0.000132	0.00113	CcSEcCtD
Ondansetron—Dyspnoea—Bupropion—obesity	0.000131	0.00113	CcSEcCtD
Ondansetron—Somnolence—Bupropion—obesity	0.000131	0.00112	CcSEcCtD
Ondansetron—Hypersensitivity—Orlistat—obesity	0.000128	0.0011	CcSEcCtD
Ondansetron—Visual impairment—Topiramate—obesity	0.000127	0.00109	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Bupropion—obesity	0.000127	0.00109	CcSEcCtD
Ondansetron—Fatigue—Bupropion—obesity	0.000127	0.00109	CcSEcCtD
Ondansetron—Pain—Bupropion—obesity	0.000126	0.00108	CcSEcCtD
Ondansetron—Constipation—Bupropion—obesity	0.000126	0.00108	CcSEcCtD
Ondansetron—Asthenia—Orlistat—obesity	0.000125	0.00108	CcSEcCtD
Ondansetron—Erythema multiforme—Topiramate—obesity	0.000124	0.00107	CcSEcCtD
Ondansetron—Hypersensitivity—Sibutramine—obesity	0.000124	0.00107	CcSEcCtD
Ondansetron—Pruritus—Orlistat—obesity	0.000123	0.00106	CcSEcCtD
Ondansetron—Eye disorder—Topiramate—obesity	0.000123	0.00106	CcSEcCtD
Ondansetron—Flushing—Topiramate—obesity	0.000122	0.00105	CcSEcCtD
Ondansetron—Cardiac disorder—Topiramate—obesity	0.000122	0.00105	CcSEcCtD
Ondansetron—Feeling abnormal—Bupropion—obesity	0.000121	0.00104	CcSEcCtD
Ondansetron—Asthenia—Sibutramine—obesity	0.000121	0.00104	CcSEcCtD
Ondansetron—Gastrointestinal pain—Bupropion—obesity	0.00012	0.00103	CcSEcCtD
Ondansetron—Angiopathy—Topiramate—obesity	0.000119	0.00103	CcSEcCtD
Ondansetron—Pruritus—Sibutramine—obesity	0.000119	0.00103	CcSEcCtD
Ondansetron—Diarrhoea—Orlistat—obesity	0.000119	0.00103	CcSEcCtD
Ondansetron—Immune system disorder—Topiramate—obesity	0.000119	0.00102	CcSEcCtD
Ondansetron—Mediastinal disorder—Topiramate—obesity	0.000119	0.00102	CcSEcCtD
Ondansetron—Chills—Topiramate—obesity	0.000118	0.00102	CcSEcCtD
Ondansetron—Urticaria—Bupropion—obesity	0.000117	0.00101	CcSEcCtD
Ondansetron—Abdominal pain—Bupropion—obesity	0.000116	0.001	CcSEcCtD
Ondansetron—Body temperature increased—Bupropion—obesity	0.000116	0.001	CcSEcCtD
Ondansetron—Diarrhoea—Sibutramine—obesity	0.000115	0.000993	CcSEcCtD
Ondansetron—Dizziness—Orlistat—obesity	0.000115	0.000992	CcSEcCtD
Ondansetron—Erythema—Topiramate—obesity	0.000115	0.000988	CcSEcCtD
Ondansetron—Flatulence—Topiramate—obesity	0.000113	0.000973	CcSEcCtD
Ondansetron—Dizziness—Sibutramine—obesity	0.000111	0.00096	CcSEcCtD
Ondansetron—Vomiting—Orlistat—obesity	0.000111	0.000953	CcSEcCtD
Ondansetron—Rash—Orlistat—obesity	0.00011	0.000945	CcSEcCtD
Ondansetron—Dermatitis—Orlistat—obesity	0.00011	0.000945	CcSEcCtD
Ondansetron—Headache—Orlistat—obesity	0.000109	0.000939	CcSEcCtD
Ondansetron—Hypersensitivity—Bupropion—obesity	0.000108	0.000932	CcSEcCtD
Ondansetron—Vision blurred—Topiramate—obesity	0.000108	0.000931	CcSEcCtD
Ondansetron—Tremor—Topiramate—obesity	0.000107	0.000925	CcSEcCtD
Ondansetron—Vomiting—Sibutramine—obesity	0.000107	0.000923	CcSEcCtD
Ondansetron—Ill-defined disorder—Topiramate—obesity	0.000106	0.000916	CcSEcCtD
Ondansetron—Rash—Sibutramine—obesity	0.000106	0.000915	CcSEcCtD
Ondansetron—Dermatitis—Sibutramine—obesity	0.000106	0.000914	CcSEcCtD
Ondansetron—Headache—Sibutramine—obesity	0.000106	0.000909	CcSEcCtD
Ondansetron—Asthenia—Bupropion—obesity	0.000105	0.000908	CcSEcCtD
Ondansetron—Agitation—Topiramate—obesity	0.000105	0.000908	CcSEcCtD
Ondansetron—Pruritus—Bupropion—obesity	0.000104	0.000895	CcSEcCtD
Ondansetron—Malaise—Topiramate—obesity	0.000103	0.000891	CcSEcCtD
Ondansetron—Syncope—Topiramate—obesity	0.000103	0.000886	CcSEcCtD
Ondansetron—Palpitations—Topiramate—obesity	0.000101	0.000873	CcSEcCtD
Ondansetron—Loss of consciousness—Topiramate—obesity	0.000101	0.000868	CcSEcCtD
Ondansetron—Diarrhoea—Bupropion—obesity	0.0001	0.000866	CcSEcCtD
Ondansetron—Cough—Topiramate—obesity	0.0001	0.000862	CcSEcCtD
Ondansetron—Convulsion—Topiramate—obesity	9.93e-05	0.000856	CcSEcCtD
Ondansetron—Chest pain—Topiramate—obesity	9.76e-05	0.000841	CcSEcCtD
Ondansetron—Anxiety—Topiramate—obesity	9.72e-05	0.000838	CcSEcCtD
Ondansetron—Dizziness—Bupropion—obesity	9.71e-05	0.000837	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	9.69e-05	0.000835	CcSEcCtD
Ondansetron—Discomfort—Topiramate—obesity	9.64e-05	0.000831	CcSEcCtD
Ondansetron—Dry mouth—Topiramate—obesity	9.54e-05	0.000822	CcSEcCtD
Ondansetron—Vomiting—Bupropion—obesity	9.34e-05	0.000804	CcSEcCtD
Ondansetron—Rash—Bupropion—obesity	9.26e-05	0.000798	CcSEcCtD
Ondansetron—Dermatitis—Bupropion—obesity	9.25e-05	0.000797	CcSEcCtD
Ondansetron—Shock—Topiramate—obesity	9.2e-05	0.000793	CcSEcCtD
Ondansetron—Headache—Bupropion—obesity	9.2e-05	0.000793	CcSEcCtD
Ondansetron—Nervous system disorder—Topiramate—obesity	9.17e-05	0.00079	CcSEcCtD
Ondansetron—Tachycardia—Topiramate—obesity	9.13e-05	0.000787	CcSEcCtD
Ondansetron—Skin disorder—Topiramate—obesity	9.09e-05	0.000783	CcSEcCtD
Ondansetron—Hypotension—Topiramate—obesity	8.74e-05	0.000753	CcSEcCtD
Ondansetron—Paraesthesia—Topiramate—obesity	8.4e-05	0.000724	CcSEcCtD
Ondansetron—Dyspnoea—Topiramate—obesity	8.34e-05	0.000719	CcSEcCtD
Ondansetron—Somnolence—Topiramate—obesity	8.32e-05	0.000717	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Topiramate—obesity	8.08e-05	0.000696	CcSEcCtD
Ondansetron—Fatigue—Topiramate—obesity	8.06e-05	0.000695	CcSEcCtD
Ondansetron—Constipation—Topiramate—obesity	8e-05	0.000689	CcSEcCtD
Ondansetron—Pain—Topiramate—obesity	8e-05	0.000689	CcSEcCtD
Ondansetron—Feeling abnormal—Topiramate—obesity	7.71e-05	0.000664	CcSEcCtD
Ondansetron—Gastrointestinal pain—Topiramate—obesity	7.65e-05	0.000659	CcSEcCtD
Ondansetron—Urticaria—Topiramate—obesity	7.43e-05	0.00064	CcSEcCtD
Ondansetron—Body temperature increased—Topiramate—obesity	7.39e-05	0.000637	CcSEcCtD
Ondansetron—Abdominal pain—Topiramate—obesity	7.39e-05	0.000637	CcSEcCtD
Ondansetron—Hypersensitivity—Topiramate—obesity	6.89e-05	0.000594	CcSEcCtD
Ondansetron—Asthenia—Topiramate—obesity	6.71e-05	0.000578	CcSEcCtD
Ondansetron—Pruritus—Topiramate—obesity	6.62e-05	0.00057	CcSEcCtD
Ondansetron—Diarrhoea—Topiramate—obesity	6.4e-05	0.000552	CcSEcCtD
Ondansetron—Dizziness—Topiramate—obesity	6.19e-05	0.000533	CcSEcCtD
Ondansetron—Vomiting—Topiramate—obesity	5.95e-05	0.000512	CcSEcCtD
Ondansetron—Rash—Topiramate—obesity	5.9e-05	0.000508	CcSEcCtD
Ondansetron—Dermatitis—Topiramate—obesity	5.89e-05	0.000508	CcSEcCtD
Ondansetron—Headache—Topiramate—obesity	5.86e-05	0.000505	CcSEcCtD
Ondansetron—CYP1A2—Metabolism—GOT2—obesity	2.28e-06	2.17e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TYK2—obesity	2.27e-06	2.17e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—AGT—obesity	2.27e-06	2.16e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—NCOA1—obesity	2.27e-06	2.16e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—AGT—obesity	2.26e-06	2.16e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SULT2A1—obesity	2.26e-06	2.16e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GLP1R—obesity	2.26e-06	2.16e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—RHOA—obesity	2.26e-06	2.15e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—STK11—obesity	2.25e-06	2.15e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CYP19A1—obesity	2.25e-06	2.15e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	2.24e-06	2.14e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CYP19A1—obesity	2.23e-06	2.13e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—STK11—obesity	2.23e-06	2.13e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PIK3R1—obesity	2.23e-06	2.13e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NOS3—obesity	2.23e-06	2.13e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—FASN—obesity	2.23e-06	2.13e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—DPYD—obesity	2.22e-06	2.12e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—APOE—obesity	2.22e-06	2.12e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—BCHE—obesity	2.22e-06	2.12e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—APOE—obesity	2.22e-06	2.12e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—POMC—obesity	2.21e-06	2.11e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CAV1—obesity	2.2e-06	2.1e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—INS—obesity	2.2e-06	2.1e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CAV1—obesity	2.19e-06	2.1e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—APOA1—obesity	2.19e-06	2.1e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—APOA1—obesity	2.19e-06	2.09e-05	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—AKT1—obesity	2.17e-06	2.07e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCL2—obesity	2.16e-06	2.07e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP2E1—obesity	2.14e-06	2.04e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PRKAR2B—obesity	2.14e-06	2.04e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—IL6—obesity	2.13e-06	2.04e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—PIK3CA—obesity	2.13e-06	2.03e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IGF1—obesity	2.13e-06	2.03e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—DCN—obesity	2.12e-06	2.03e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—AKT2—obesity	2.12e-06	2.03e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PIK3CB—obesity	2.12e-06	2.02e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—NQO1—obesity	2.12e-06	2.02e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PTGS2—obesity	2.1e-06	2.01e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—COMT—obesity	2.09e-06	2e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—COMT—obesity	2.08e-06	1.98e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	2.07e-06	1.98e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CPT1A—obesity	2.07e-06	1.97e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PPARGC1A—obesity	2.06e-06	1.97e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GNB3—obesity	2.06e-06	1.97e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MTOR—obesity	2.06e-06	1.97e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PIK3CB—obesity	2.06e-06	1.97e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—HMOX1—obesity	2.05e-06	1.96e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.05e-06	1.96e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PPARGC1A—obesity	2.05e-06	1.95e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GNB3—obesity	2.05e-06	1.95e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PIK3CD—obesity	2.04e-06	1.95e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—HMOX1—obesity	2.04e-06	1.95e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MMP9—obesity	2.03e-06	1.94e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—SLC2A4—obesity	2.03e-06	1.94e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GCG—obesity	2.03e-06	1.94e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—NAMPT—obesity	2.03e-06	1.94e-05	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—PIK3CA—obesity	2.02e-06	1.93e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SERPINE1—obesity	2.02e-06	1.93e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GCK—obesity	2.01e-06	1.92e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—LIPC—obesity	2.01e-06	1.92e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GNAS—obesity	2.01e-06	1.92e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PIK3CG—obesity	2e-06	1.91e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYCS—obesity	2e-06	1.91e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—APOC3—obesity	2e-06	1.91e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PIK3CG—obesity	2e-06	1.91e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GNAS—obesity	1.99e-06	1.9e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MAPK8—obesity	1.97e-06	1.89e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—AKT1—obesity	1.97e-06	1.88e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—APOB—obesity	1.97e-06	1.88e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GGT1—obesity	1.96e-06	1.88e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GOT1—obesity	1.96e-06	1.88e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TYK2—obesity	1.96e-06	1.88e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—APOB—obesity	1.95e-06	1.86e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—RHOA—obesity	1.95e-06	1.86e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CETP—obesity	1.94e-06	1.86e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—NCOA1—obesity	1.94e-06	1.85e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PPARG—obesity	1.93e-06	1.85e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PPARG—obesity	1.93e-06	1.84e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PIK3R1—obesity	1.93e-06	1.84e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NOS3—obesity	1.93e-06	1.84e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SDC1—obesity	1.92e-06	1.83e-05	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—AKT1—obesity	1.91e-06	1.83e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—STK11—obesity	1.91e-06	1.82e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP19A1—obesity	1.91e-06	1.82e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—POMC—obesity	1.91e-06	1.82e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—POMC—obesity	1.9e-06	1.82e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—INS—obesity	1.9e-06	1.81e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—INS—obesity	1.89e-06	1.81e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—AKR1C3—obesity	1.89e-06	1.81e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—IL6—obesity	1.88e-06	1.8e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—LPL—obesity	1.88e-06	1.8e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—LPL—obesity	1.86e-06	1.78e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SCARB1—obesity	1.86e-06	1.78e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—PIK3CA—obesity	1.84e-06	1.75e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GPX1—obesity	1.83e-06	1.75e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GPX1—obesity	1.82e-06	1.74e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SREBF1—obesity	1.81e-06	1.73e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—STAT3—obesity	1.8e-06	1.72e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MMP9—obesity	1.79e-06	1.71e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CD36—obesity	1.79e-06	1.71e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MTOR—obesity	1.78e-06	1.7e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PIK3CB—obesity	1.78e-06	1.7e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—COMT—obesity	1.77e-06	1.69e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CD36—obesity	1.77e-06	1.69e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PIK3CD—obesity	1.76e-06	1.68e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PIK3CD—obesity	1.76e-06	1.68e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GOT2—obesity	1.76e-06	1.68e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GNB3—obesity	1.75e-06	1.67e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PPARGC1A—obesity	1.75e-06	1.67e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MAPK8—obesity	1.74e-06	1.66e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—HMOX1—obesity	1.74e-06	1.66e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ALB—obesity	1.74e-06	1.66e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—AKT1—obesity	1.74e-06	1.66e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ALB—obesity	1.74e-06	1.66e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—FASN—obesity	1.72e-06	1.64e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—BCHE—obesity	1.71e-06	1.64e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GNAS—obesity	1.7e-06	1.63e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—MTHFR—obesity	1.69e-06	1.62e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—MTHFR—obesity	1.68e-06	1.6e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MYC—obesity	1.68e-06	1.6e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TGFB1—obesity	1.67e-06	1.6e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—APOB—obesity	1.67e-06	1.59e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PIK3R1—obesity	1.66e-06	1.59e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—NOS3—obesity	1.66e-06	1.59e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PPARA—obesity	1.66e-06	1.59e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PIK3R1—obesity	1.66e-06	1.59e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—NOS3—obesity	1.66e-06	1.59e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP2E1—obesity	1.65e-06	1.58e-05	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—AKT1—obesity	1.65e-06	1.58e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PPARA—obesity	1.65e-06	1.57e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—NQO1—obesity	1.63e-06	1.56e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL6—obesity	1.63e-06	1.55e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—AGT—obesity	1.61e-06	1.54e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—AGT—obesity	1.59e-06	1.52e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—STAT3—obesity	1.59e-06	1.52e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—LPL—obesity	1.59e-06	1.52e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—APOE—obesity	1.58e-06	1.5e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GCG—obesity	1.57e-06	1.5e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SLC2A4—obesity	1.57e-06	1.5e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—APOE—obesity	1.56e-06	1.49e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CAV1—obesity	1.56e-06	1.49e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—APOA1—obesity	1.56e-06	1.49e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GPX1—obesity	1.55e-06	1.48e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CAV1—obesity	1.55e-06	1.48e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MMP9—obesity	1.55e-06	1.48e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYCS—obesity	1.55e-06	1.48e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—APOA1—obesity	1.54e-06	1.47e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PIK3CB—obesity	1.54e-06	1.47e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PIK3CB—obesity	1.53e-06	1.46e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PTGS2—obesity	1.52e-06	1.45e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PTGS2—obesity	1.52e-06	1.45e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GOT1—obesity	1.52e-06	1.45e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GGT1—obesity	1.52e-06	1.45e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CD36—obesity	1.51e-06	1.45e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MAPK8—obesity	1.5e-06	1.44e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—AKT1—obesity	1.5e-06	1.43e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—NCOA1—obesity	1.49e-06	1.43e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MYC—obesity	1.48e-06	1.41e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.48e-06	1.41e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TGFB1—obesity	1.48e-06	1.41e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—STK11—obesity	1.47e-06	1.41e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP19A1—obesity	1.47e-06	1.41e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—MTHFR—obesity	1.43e-06	1.37e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PIK3CA—obesity	1.42e-06	1.36e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PIK3CG—obesity	1.42e-06	1.36e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PIK3CG—obesity	1.41e-06	1.35e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PPARA—obesity	1.41e-06	1.34e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—STAT3—obesity	1.37e-06	1.31e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PPARG—obesity	1.37e-06	1.31e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—COMT—obesity	1.37e-06	1.31e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—AGT—obesity	1.36e-06	1.3e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PPARG—obesity	1.36e-06	1.3e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—POMC—obesity	1.35e-06	1.29e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PPARGC1A—obesity	1.35e-06	1.29e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GNB3—obesity	1.35e-06	1.29e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—INS—obesity	1.35e-06	1.29e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—HMOX1—obesity	1.34e-06	1.28e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—POMC—obesity	1.34e-06	1.28e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—APOE—obesity	1.33e-06	1.27e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—INS—obesity	1.33e-06	1.27e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CAV1—obesity	1.32e-06	1.26e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—APOA1—obesity	1.32e-06	1.26e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GNAS—obesity	1.31e-06	1.26e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PIK3CA—obesity	1.29e-06	1.23e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—APOB—obesity	1.29e-06	1.23e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MYC—obesity	1.28e-06	1.22e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TGFB1—obesity	1.27e-06	1.22e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.26e-06	1.21e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL6—obesity	1.26e-06	1.2e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PIK3CA—obesity	1.26e-06	1.2e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PIK3CD—obesity	1.25e-06	1.19e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PIK3CD—obesity	1.24e-06	1.18e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ALB—obesity	1.23e-06	1.18e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—LPL—obesity	1.23e-06	1.17e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ALB—obesity	1.22e-06	1.17e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PIK3CG—obesity	1.2e-06	1.15e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GPX1—obesity	1.2e-06	1.15e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PIK3R1—obesity	1.18e-06	1.13e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—NOS3—obesity	1.18e-06	1.13e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PIK3R1—obesity	1.17e-06	1.12e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—NOS3—obesity	1.17e-06	1.12e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CD36—obesity	1.17e-06	1.12e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—AKT1—obesity	1.16e-06	1.11e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PPARG—obesity	1.16e-06	1.11e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—POMC—obesity	1.15e-06	1.1e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—INS—obesity	1.14e-06	1.09e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL6—obesity	1.11e-06	1.06e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—MTHFR—obesity	1.11e-06	1.06e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PIK3CB—obesity	1.09e-06	1.04e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PPARA—obesity	1.09e-06	1.04e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PIK3CA—obesity	1.08e-06	1.04e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PIK3CB—obesity	1.08e-06	1.03e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PTGS2—obesity	1.08e-06	1.03e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PTGS2—obesity	1.07e-06	1.02e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PIK3CD—obesity	1.06e-06	1.01e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—AKT1—obesity	1.06e-06	1.01e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—AGT—obesity	1.05e-06	1e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ALB—obesity	1.05e-06	9.98e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—APOE—obesity	1.03e-06	9.84e-06	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—AKT1—obesity	1.03e-06	9.8e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CAV1—obesity	1.02e-06	9.75e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—APOA1—obesity	1.02e-06	9.73e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—NOS3—obesity	1e-06	9.55e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PIK3R1—obesity	1e-06	9.55e-06	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL6—obesity	9.6e-07	9.17e-06	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PIK3CA—obesity	9.36e-07	8.94e-06	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PIK3CA—obesity	9.34e-07	8.92e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PIK3CG—obesity	9.3e-07	8.88e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PIK3CB—obesity	9.23e-07	8.82e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PTGS2—obesity	9.14e-07	8.74e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PPARG—obesity	8.97e-07	8.57e-06	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—AKT1—obesity	8.86e-07	8.46e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—POMC—obesity	8.85e-07	8.45e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—INS—obesity	8.8e-07	8.41e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PIK3CD—obesity	8.17e-07	7.81e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ALB—obesity	8.07e-07	7.71e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PIK3R1—obesity	7.72e-07	7.37e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—NOS3—obesity	7.72e-07	7.37e-06	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—AKT1—obesity	7.65e-07	7.3e-06	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—AKT1—obesity	7.63e-07	7.29e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PIK3CB—obesity	7.12e-07	6.8e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PTGS2—obesity	7.06e-07	6.74e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PIK3CA—obesity	6.64e-07	6.34e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PIK3CA—obesity	6.58e-07	6.29e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PIK3CA—obesity	5.63e-07	5.37e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—AKT1—obesity	5.43e-07	5.18e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—AKT1—obesity	5.38e-07	5.14e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—AKT1—obesity	4.6e-07	4.39e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PIK3CA—obesity	4.34e-07	4.15e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—AKT1—obesity	3.55e-07	3.39e-06	CbGpPWpGaD
